BPC-157
Body Protection Compound
A 15-amino-acid partial sequence of the body-protection compound found in gastric juice. Widely studied for its role in accelerating soft-tissue repair, supporting gut mucosal integrity, and modulating inflammatory cascades at the cellular level.
Format
5mg / vial
Purity
>99.4%
Category
Recovery
Storage
2–8 °C
Research Price
€89
5mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Research Protocol Bundles
Recovery Stack
BPC-157 + TB-500 + GHK-Cu
The gold-standard soft-tissue repair protocol. Combines systemic repair (TB-500), localised healing (BPC-157), and skin/collagen regeneration (GHK-Cu) into a synergistic three-compound cycle.
Bundle total
€262
10% bundle saving
Documented Research Parameters
Research Dose
250–500 mcg
Frequency
1–2× daily
Duration
4–12 weeks
Half-Life
~4 hours
Route(s)
Subcutaneous · Intramuscular
Solubility
Water or 0.5% acetic acid
Reconstitution
2 ml bacteriostatic water per 5 mg vial
Key Research Findings
Stable in gastric juice — widely studied via both oral and parenteral routes in animal models.
Upregulates growth hormone receptor expression in tendon fibroblasts.
Modulates dopaminergic and serotonergic neurotransmission in CNS research models.
Demonstrated gastroprotective effects in NSAID-induced ulcer models.
Administration Reference
In research models, subcutaneous administration near the site of injury has been explored to maximise local bioavailability. Common sites studied include the abdomen, outer thigh, and deltoid region. Intramuscular administration into the vastus lateralis is also documented. Rotate sites between administrations. Standard insulin syringes (29–31G, 4–8 mm) are appropriate for reconstituted peptide solutions.
Documented Combination Protocols
Synergistic angiogenesis and musculoskeletal repair — the most studied recovery stack in the literature.
Combined collagen signalling and anti-inflammatory effect for connective tissue research.
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.